电艾灸治疗膝骨关节炎的疗效与安全性:随机对照试验方案
本研究为多中心、随机、开放、评估者盲法、平行组临床试验,计划纳入138例膝骨关节炎患者,按1:1:1随机分为电艾灸组、传统间接艾灸组和常规护理组。主要结局为第1周至第6周疼痛数值评定量表(NRS)变化,并评估安全性。
要点
- 电艾灸组接受6周共12次治疗,每次刺激6个穴位(ST36、ST35、ST34、SP9、EX-LE4、SP10),必要时加最多2个阿是穴。
- 主要结局为第1周至第6周NRS疼痛变化,次要结局包括VAS疼痛、K-WOMAC、PGA和EQ-5D-5L。
- 安全性通过每次访视时监测不良事件评估,随访至基线后12周。
核心结论
- 本试验旨在评估电艾灸治疗膝骨关节炎的疗效与安全性,并与传统间接艾灸和常规护理进行比较。
研究设计与样本
- 多中心、随机、开放、评估者盲法、平行组临床试验,计划纳入138例膝骨关节炎患者,按1:1:1随机分为电艾灸组、传统间接艾灸组和常规护理组。
关键数值与推荐
- 主要结局为第1周至第6周疼痛数值评定量表(NRS)变化。
- 次要结局包括视觉模拟量表(VAS)疼痛、韩国版西安大略和麦克马斯特骨关节炎指数(K-WOMAC)、患者总体评估(PGA)和欧洲五维五水平健康量表(EQ-5D-5L)。
- 电艾灸组和传统间接艾灸组均接受6周内12次艾灸治疗(每周2次),刺激6个穴位(ST36、ST35、ST34、SP9、EX-LE4、SP10),必要时加最多2个阿是穴。
- 安全性通过每次访视时监测不良事件评估。
- 随访测量在基线测量后12周进行。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Knee osteoarthritis (KOA) is a significant health issue because it causes pain and functional limitation. Many studies have reported that moxibustion, a treatment in traditional Korean medicine, is effective in treating KOA. However, conventional moxibustion produces smoke, harmful gases, and odors that can adversely affect the eyes, skin, and throat. It is also difficult to control the intensity of stimulation in conventional moxibustion. An electrical moxibustion device was developed to circumvent these problems, but there are few studies of that device. We will evaluate the efficacy and safety of electrical moxibustion as a treatment for KOA, and compare it with traditional indirect moxibustion and usual care. METHODS: This is a multicenter, randomized, open, assessor-blinded, parallel-group clinical trial. A total of 138 eligible participants with KOA will be randomly allocated into three groups (electrical moxibustion, traditional indirect moxibustion, or usual care) with a 1:1:1 ratio. Participants in each moxibustion group will receive 12 sessions of moxibustion treatment at 6 acupoints (ST36, ST35, ST34, SP9, EX-LE4, SP10) plus up to 2 points of "ashi", if needed, over a period of 6 weeks (2 sessions per week). A specifically designed device that provides thermal stimulation using electrical energy will be used for the electrical moxibustion group. Participants in the usual care group will receive usual treatment and self-care. The primary outcome measure is change in pain on a numerical rating scale (NRS) from week 1 to week 6. The secondary outcome measures are pain assessed on a visual analog scale (VAS), the Korean version of the Western Ontario and McMaster osteoarthritis index (K-WOMAC), patient global assessment (PGA), and the European quality of life five dimension five level scale (EQ-5D-5 L). Safety will be assessed by monitoring adverse events at each visit. Follow-up measurements will be performed at 12 weeks after baseline measurements. DISCUSSION: This trial will provide evidence on the efficacy and safety of electrical moxibustion as a treatment for KOA. TRIAL REGISTRATION: ClinicalTrials.gov, NCT03287570 . Registered on 19 September 2017.
引用
- Kang HR, Jung CY, Lee SD, et al. Efficacy and safety of electrical moxibustion for knee osteoarthritis: study protocol for a randomized controlled trial. Trials. 2018. PMID: 29506572. doi:10.1186/s13063-018-2514-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。